ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC) is an aggressive subset of breast cancer that lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [4,5].